Overview
Thomas Gribbin is a Hematologist Oncology specialist and a Hematologist in Roseville, Michigan. Dr. Gribbin is rated as an Advanced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Paget Disease of the Breast, Breast Cancer, Embryonal Tumor with Multilayered Rosettes, Gliosarcoma, and Bone Marrow Aspiration. Dr. Gribbin is currently accepting new patients.
His clinical research consists of co-authoring 2 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- POS
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
18223 E 10 Mile Rd, Suite 100, Roseville, MI 48066
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Regents Of The University Of Michigan
Erica Campagnaro is a Hematologist and an Oncologist in Ann Arbor, Michigan. Dr. Campagnaro is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). Her top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Monoclonal Gammopathy of Undetermined Significance (MGUS), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Campagnaro is currently accepting new patients.
Ascension St John Hospital
Daniel Lebovic is a Hematologist Oncology specialist and an Oncologist in Grosse Pointe Woods, Michigan. Dr. Lebovic is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Monoclonal Gammopathy of Undetermined Significance (MGUS), Polycythemia Vera, Schnitzler Syndrome, Bone Marrow Aspiration, and Endoscopy. Dr. Lebovic is currently accepting new patients.
Henry Ford Health System
Bernd Barthel is an Oncologist and a Hematologist Oncology provider in Detroit, Michigan. Dr. Barthel is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Primary Lymphoma of the Brain, Monoclonal Gammopathy of Undetermined Significance (MGUS), Thrombocytopenia, Schnitzler Syndrome, and Bone Marrow Aspiration. Dr. Barthel is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- AstrocytomaDr. Gribbin isDistinguished. Learn about Astrocytoma.
- Atypical Teratoid Rhabdoid Tumor (ATRT)Dr. Gribbin isDistinguished. Learn about Atypical Teratoid Rhabdoid Tumor (ATRT).
- Breast CancerDr. Gribbin isDistinguished. Learn about Breast Cancer.
- Embryonal Tumor with Multilayered RosettesDr. Gribbin isDistinguished. Learn about Embryonal Tumor with Multilayered Rosettes.
- GliosarcomaDr. Gribbin isDistinguished. Learn about Gliosarcoma.
- NeuroepitheliomaDr. Gribbin isDistinguished. Learn about Neuroepithelioma.
- Advanced
- AngiosarcomaDr. Gribbin isAdvanced. Learn about Angiosarcoma.
- Brain TumorDr. Gribbin isAdvanced. Learn about Brain Tumor.
- Breast Cancer in MenDr. Gribbin isAdvanced. Learn about Breast Cancer in Men.
- Chronic B-Cell Leukemia (CBCL)Dr. Gribbin isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Dr. Gribbin isAdvanced. Learn about Chronic Lymphocytic Leukemia (CLL).
- Colorectal CancerDr. Gribbin isAdvanced. Learn about Colorectal Cancer.
- Experienced
- Acute Hepatic Porphyria (AHP)Dr. Gribbin isExperienced. Learn about Acute Hepatic Porphyria (AHP).
- Acute Intermittent PorphyriaDr. Gribbin isExperienced. Learn about Acute Intermittent Porphyria.
- Acute Lymphoblastic Leukemia (ALL)Dr. Gribbin isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Gribbin isExperienced. Learn about Acute Myeloid Leukemia (AML).